Vir Biotechnology Inc
NASDAQ:VIR

Watchlist Manager
Vir Biotechnology Inc Logo
Vir Biotechnology Inc
NASDAQ:VIR
Watchlist
Price: 6.03 USD
Market Cap: 839m USD

Relative Value

The Relative Value of one VIR stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.03 USD, Vir Biotechnology Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
11
vs Industry
38
Median 3Y
14.9
Median 5Y
15.7
Industry
7.9
Forward
130.6
vs History
vs Industry
12
Median 3Y
-2
Median 5Y
-2.2
Industry
23.7
Forward
-1.7
vs History
vs Industry
14
Median 3Y
-1.8
Median 5Y
-2
Industry
22
vs History
vs Industry
10
Median 3Y
-1.8
Median 5Y
-2
Industry
24.3
vs History
56
vs Industry
63
Median 3Y
0.9
Median 5Y
1.4
Industry
3.3
vs History
17
vs Industry
76
Median 3Y
1.8
Median 5Y
2.5
Industry
8.2
Forward
51.7
vs History
11
vs Industry
77
Median 3Y
1.9
Median 5Y
1.9
Industry
10.2
vs History
vs Industry
30
Median 3Y
-0.2
Median 5Y
-0.2
Industry
6.1
Forward
-0.6
vs History
vs Industry
28
Median 3Y
-0.2
Median 5Y
-0.2
Industry
6.5
Forward
-0.6
vs History
vs Industry
32
Median 3Y
-0.1
Median 5Y
-0.2
Industry
7.9
vs History
vs Industry
28
Median 3Y
-0.1
Median 5Y
-0.2
Industry
6.3
vs History
53
vs Industry
69
Median 3Y
0.3
Median 5Y
1.1
Industry
5.7

Multiples Across Competitors

VIR Competitors Multiples
Vir Biotechnology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Vir Biotechnology Inc
NASDAQ:VIR
838.3m USD 49.7 -1.7 -0.6 -0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
403.8B USD 6.8 172 16.6 23.6
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
152.4B USD 5.2 18.8 12.6 12.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 9.8 31.3 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.7 17.8 16.9 19.2
AU
CSL Ltd
ASX:CSL
83.6B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 203 162.2 196.7
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.3 33.6 57.9 59.5
P/E Multiple
Earnings Growth PEG
US
Vir Biotechnology Inc
NASDAQ:VIR
Average P/E: 190
Negative Multiple: -1.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.8
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 203
N/A N/A
NL
argenx SE
XBRU:ARGX
33.6
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Vir Biotechnology Inc
NASDAQ:VIR
Average EV/EBITDA: 40
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.2
N/A N/A
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Vir Biotechnology Inc
NASDAQ:VIR
Average EV/EBIT: 46.2
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.6
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.7
N/A N/A
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A